Effect of Opioids on Ventilation in Children With Obstructive Sleep Apnea

NCT03938259 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 52

Last updated 2024-07-26

Study results available
· View outcomes & findings →

Summary

The sole objective in this study is to evaluate if routine amounts of opioids given for tonsillectomy in children have greater amounts of respiratory depression in children with documented obstructive sleep apnea when compared with patients that do not have obstructive sleep apnea

Conditions

Interventions

DRUG

Fentanyl

identification of respiratory parameter changes following administration of fentanyl in children with and without OSA

Sponsors & Collaborators

  • Baylor College of Medicine

    lead OTHER

Principal Investigators

  • adam adler, MD · Baylor College of Medicine

Eligibility

Min Age
2 Years
Max Age
8 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-07-01
Primary Completion
2020-08-30
Completion
2020-08-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03938259 on ClinicalTrials.gov